Researching Parkinson's

The last three decades of research have gone a long way to lay foundations for a range of modern tests, trials and research into the causes and cures of Parkinson's.   It is hoped that further progression in terms of research will ensure that in the near future, patients can benefit from heightened levels of more effective treatment and perhaps even the elusive cure, or prevention methods.  Whilst some researchers are investigating the condition, and how it impacts upon the body and the brain, others focus primarily on the four main causal theories, and are attempting to definitively come up with solutions to these causes.  Of the millions spent each year in research, results are slow, although comfort can be taken in the fact that they are progressing all the time, and there is a reasonable chance we will know more tomorrow than we did today about this dreadful condition.

Another subject under scrutiny is the possibility of surgically grafting nerves to the brain to promote the production of the drug dopamine, vital for movement.  Until now, no procedure or treatment has come close to achieving this goal, and this is something that is the subject of numerous trials and tests to figure the most effective method of surgery as well as the actual probability of success of such an operation. 

Additionally, the discovery of toxins which induce the condition has allowed scientists to continue testing to learn more about the mechanisms of Parkinson's, and how the disease evolves and develops within patients.  It is now possible to artificially induce the condition in animals under laboratory conditions, and come up with suitable ways of calming the symptoms, or perhaps preventing them altogether.

Other subjects under investigation relate to the drugs currently available for treatment of Parkinson's disease and the development thereof, with particular emphasis on controlled-release properties, which would act to minimise the potential side effects and maximise the impact of the drugs designed to promote dopamine within the brain.  Another treatment in testing involves the implant of dopamine capsules into the brain, with timed release capabilities, although these are still some way off mainstream medical consideration.

Scientists are also concerned with different ways in which dopamine can be created in other parts of the brain.  In animal testing, it has been shown that by increasing dopamine production elsewhere in the brain, the symptoms of Parkinson's can be somewhat alleviated, which is thought to have transferable potential for humans suffering from the condition.

The future is sure to yield many promising developments, and perhaps one day Parkinson's will be a condition of the past.  However, in the interim, it is crucial to keep faith in the current treatments and medications in a bid to halt the developments of the condition and promote extended healthy and happy lives for the patients this disease affects.  Research is continually ongoing into a diverse range of related issues, and this will hopefully pay dividends in knowledge on the condition in the years to follow.

Parkinson's news on the Web

Alnylam Evenly Poised Alnylam???s founders pioneered the discovery of RNAi, and the company is currently utilizing this technology to build a pipeline of drug candidates for the treatment of a wide array of diseases.

Press Release Economic pressures have forced Big Biotech companies to reevaluate their business strategies in order to minimize costs and prioritize therapy areas that will drive top-line growth.

Research and Markets: Executing Change: Survival Strategies of Big Biotech DUBLIN----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Executing Change: Survival Strategies of Big Biotech" to their offering.

Verna’s Victory THESE days it is fashionable to celebrate the life of someone who has died, unlike in the past where we just mourned that person’s death. Well and good, it is mentally healthier to do so.

Research and Markets: Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts ... DUBLIN----Research and Markets has announced the addition of GlobalData 's new report "Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" to their offering.

NIH Issues New Stem Cell Research Guidelines as Obama Administration Prepares to Appeal Court Ruling The National Institutes of Health (NIH) -- still reeling from a District Court ruling that blocked the use of federal funds for embryonic cell research -- issued new guidance last night detailing how it will comply with the Court's preliminary injunction. National Institutes of Health - Injunction - District Court - Stem cell - Research

What's on this weekend? Whether it's an indoors event you're looking for, or something with a bit of fresh air attached, there's always something for you to do.

Van Horn grad ready to play against Parkinson's Drew Dimmel says he has watched the best parade in the world pass by the last 62 years – his life.

Parkinson's disease linked to immune system gene Researchers found a gene in a region that contains a many of genes related to fighting infections was strongly linked with Parkinson's disease.

Dogfight expensive ordeal for both Ogden owners OGDEN -- Isis and Oggie are dogs who hate each other's guts. This vitriolic relationship got them and their owners into very expensive trouble. read more